CRP and cancer: Epidemiologic studies suggest that in patients with several types of solid cancers, elevated circulating levels of C-reactive protein (CRP) are associated with poor prognosis, whereas in apparently healthy individuals from the general population, elevated levels of CRP are associated with increased future risk of cancer of any type (156).